On the other hand, miR-223 is significantly up-regulated in bladder cancers [15], recurrent ovarian cancer [16] and increases cyclin E protein and activity levels, and elevates genomic instability [23]. This evidence concerns the gene CCNE1 and urinary bladder carcinoma.